- Home
- NTGR vs BCYC Comparison
NTGR vs BCYC Comparison
Compare NTGR & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTGR
- BCYC
- Stock Information
- Founded
- NTGR 1996
- BCYC 2009
- Country
- NTGR United States
- BCYC United Kingdom
- Employees
- NTGR N/A
- BCYC N/A
- Industry
- NTGR Telecommunications Equipment
- BCYC Biotechnology: Pharmaceutical Preparations
- Sector
- NTGR Utilities
- BCYC Health Care
- Exchange
- NTGR Nasdaq
- BCYC Nasdaq
- Market Cap
- NTGR 638.3M
- BCYC 566.5M
- IPO Year
- NTGR N/A
- BCYC 2019
- Fundamental
- Price
- NTGR $29.33
- BCYC $8.22
- Analyst Decision
- NTGR Buy
- BCYC Buy
- Analyst Count
- NTGR 1
- BCYC 10
- Target Price
- NTGR $29.00
- BCYC $25.00
- AVG Volume (30 Days)
- NTGR 511.5K
- BCYC 333.0K
- Earning Date
- NTGR 04-30-2025
- BCYC 05-01-2025
- Dividend Yield
- NTGR N/A
- BCYC N/A
- EPS Growth
- NTGR N/A
- BCYC N/A
- EPS
- NTGR 0.85
- BCYC N/A
- Revenue
- NTGR $671,233,000.00
- BCYC $25,722,000.00
- Revenue This Year
- NTGR $4.48
- BCYC N/A
- Revenue Next Year
- NTGR $5.04
- BCYC $1.83
- P/E Ratio
- NTGR $34.69
- BCYC N/A
- Revenue Growth
- NTGR N/A
- BCYC N/A
- 52 Week Low
- NTGR $13.22
- BCYC $6.10
- 52 Week High
- NTGR $31.55
- BCYC $28.67
- Technical
- Relative Strength Index (RSI)
- NTGR 56.36
- BCYC 49.16
- Support Level
- NTGR $28.73
- BCYC $8.00
- Resistance Level
- NTGR $31.15
- BCYC $8.73
- Average True Range (ATR)
- NTGR 1.02
- BCYC 0.48
- MACD
- NTGR -0.22
- BCYC 0.02
- Stochastic Oscillator
- NTGR 26.62
- BCYC 33.33
About NTGR NETGEAR Inc.
Netgear Inc is a provider of networking solutions. The reportable segments of the company are connected home, and Small and Medium Businesses (SMB). The Connected Home segment focuses on consumers and consists of high-performance, dependable, and easy-to-use 4G/5G mobile, Wi-Fi internet networking solutions, and smart devices such as Orbi Voice smart speakers and Meural digital canvas; and NETGEAR specializes in providing networking solutions for businesses, including wireless LAN, Pro AV applications for audio and video over Ethernet, security, and remote management.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.